Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.56 SEK | -2.67% | -10.63% | -6.29% |
04-02 | ChromoGenics AB Receives First Order for North America | CI |
03-08 | ChromoGenics AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2023 | 13.64M 1.25M 1.72M | Sales 2024 * | 29M 2.66M 3.65M | Capitalization | 44.69M 4.1M 5.63M |
---|---|---|---|---|---|
Net income 2023 | -52M -4.77M -6.55M | Net income 2024 * | -28M -2.57M -3.52M | EV / Sales 2023 | 6.43 x |
Net Debt 2023 | 58.89M 5.4M 7.41M | Net Debt 2024 * | 89.6M 8.21M 11.28M | EV / Sales 2024 * | 4.63 x |
P/E ratio 2023 |
-0.35
x | P/E ratio 2024 * |
-1.69
x | Employees | 33 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 42.99% |
1 day | -2.67% | ||
1 week | -10.63% | ||
Current month | +0.92% | ||
1 month | -2.09% | ||
3 months | -12.77% | ||
6 months | +16.11% | ||
Current year | -6.29% |
Managers | Title | Age | Since |
---|---|---|---|
Fredrik Fränding
CEO | Chief Executive Officer | 51 | 21-07-31 |
Director of Finance/CFO | - | 23-06-11 | |
Victor Hägglund
COO | Chief Operating Officer | 37 | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 79 | 10-05-31 | |
Director/Board Member | 72 | 17-04-30 | |
Johan Olov Hedin
CHM | Chairman | 61 | 19-05-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 6.56 | -2.67% | 893 |
24-04-30 | 6.74 | -0.59% | 216 |
24-04-29 | 6.78 | 0.00% | 38 |
24-04-26 | 6.78 | -3.14% | 714 |
24-04-25 | 7 | -3.58% | 3,953 |
Delayed Quote Nasdaq Stockholm, May 02, 2024 at 07:02 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.29% | 4.07M | |
+13.39% | 14.57B | |
+16.70% | 7.01B | |
+3.70% | 2.33B | |
+15.59% | 1.11B | |
+22.43% | 812M | |
+1.25% | 410M | |
+6.84% | 364M | |
+7.24% | 232M | |
+14.62% | 190M |
- Stock Market
- Equities
- CHRO Stock